AbbVie has turned to award-winning, Oscar-nominated director Dominic Gill to help it highlight the lives of people living ...

The announcement takes the total raised by Sofinnova Partners in the last year to €1.5 billion, and comes shortly after Anglo ...

A 2024 survey by the American Medical Association showed that physician usage of AI jumped 78% in a single year, which tells ...

The FDA is also requiring Sarepta to conduct an additional post-marketing observational study to further assess the risk of ...

MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a ...

On World Diabetes Day, Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug ...

In a statement, Avadel acknowledged that it had received the Lundbeck bid and that its board of directors had "determined in ...

Alkermes already has positive results for alixorexton in NT1 from the phase 2 Vibrance-1, while Takeda is developing another ...

The $6.7 billion merger brought together two companies that had been forced to file for bankruptcy protection due to opioid ...

The growth of the stronger product – which now accounts for more than a quarter of Eylea sales – allowed Bayer to predict ...

Roche has built the evidence for its oral BTK inhibitor fenebrutinib in multiple sclerosis (MS) with two phase 3 readouts ...